Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. by Haas, Andreas D et al.
RESEARCH ARTICLE
Mental health, substance use and viral suppression in adolescents
receiving ART at a paediatric HIV clinic in South Africa
Andreas D Haas1,§,* , Karl-G€unter Technau2,3,*, Shenaaz Pahad3, Kate Braithwaite2, Mampho Madzivhandila2,
Gillian Sorour2, Shobna Sawry3 , Nicola Maxwell4, Per von Groote1, Mpho Tlali4, Mary-Ann Davies4,* ,
Matthias Egger1,4,5,* and for the IeDEA Southern Africa Collaboration
§Corresponding author: Andreas D Haas, ISPM, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland. Tel: +41 31 631 35 23. (andreas.haas@ispm.unibe.ch)
*These authors have contributed equally to the work.
Abstract
Introduction: Mental health problems are prevalent in adolescents living with HIV (ALHIV), often remain untreated, and may
negatively affect antiretroviral therapy (ART) adherence and viral suppression. We implemented routine mental health screen-
ing at a paediatric ART clinic to improve the identification and management of mental health problems in ALHIV. In this report,
we examine screening outcomes, associated patient characteristics and the odds of unsuppressed viral load in ALHIV screening
positive for mental disorders.
Methods: Adolescents aged 10 to 19 years attending Rahima Moosa Hospital in Johannesburg, South Africa between Febru-
ary 1, 2018, and January 1, 2020, were offered mental health screening at each routine HIV care visit. The screening included
four pre-screening questions followed by full screening (conditional on positive pre-screening) for depression (Patient Health
Questionnaire-9 [PHQ-9]), suicide (Adolescent Innovations Project [AIP]-handbook), anxiety (Generalized Anxiety Disorder-7
[GAD-7]), post-traumatic stress disorder (PTSD) (Primary Care PTSD Screen [PC-PTSD-5]) and substance use (CAGE Adapted
to Include Drugs [CAGE-AID]). We assessed screening outcomes and calculated adjusted odds ratios for associations between
positive screening tests at the first screen and unsuppressed viral load (>400 copies/mL) at the measurement taken closest to
the date of screening, within hundred days before and one day after screening.
Results: Out of 1203 adolescents who attended the clinic, 1088 (90.4%) were pre-screened of whom 381 (35.0%) underwent
full screening, 48 (4.4%) screened positive for depression (PHQ-9 ≥10), 29 (2.8%) for suicidal concern, 24 (2.2%) for anxiety
(GAD-7 ≥10), 38 (3.2%) for PTSD (PC-PTSD-5 ≥3), 18 (1.7%) for substance use (CAGE-AID ≥2) and 97 (8.9%) for any of these
conditions. Positive screening for depression (aOR 2.39, 95% CI 1.02 to 5.62), PTSD (aOR 3.18, 95% CI 1.11 to 9.07), sub-
stance use (aOR 7.13, 95% CI 1.60 to 31.86), or any condition (aOR 2.17, 95% CI 1.17 to 4.02) were strongly associated with
unsuppressed viral load.
Conclusions: ALHIV affected by mental health problems have increased rates of unsuppressed viral load and need specific
clinical attention. The integration of routine mental health screening in paediatric ART programmes is a feasible approach for
identifying and referring adolescents with mental health and adherence problems to counselling and psychosocial support ser-
vices and if needed to psychiatric care.
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1 | INTRODUCTION
In 2018, there were an estimated 1.6 million adolescents
(aged 10 to 19 years) living with HIV (ALHIV) globally [1]. The
majority of ALHIV live in sub-Saharan Africa, and about 20%
in South Africa [1]. ALHIV are a heterogeneous group com-
prising of those who acquired HIV perinatally and survived
into adolescence and those who acquired HIV through sexual
transmission [2-4]. In South Africa, the majority of ALHIV
enrolled in HIV care, acquired HIV perinatally [5].
For a variety of reasons, ALHIV are at risk of developing men-
tal health complications, including depression, anxiety and post-
traumatic stress disorder (PTSD). HIV infection may have a
direct effect on the brain, which can lead to neurocognitive
decline, behavioural disturbance, mood disorders and psychosis
[6]. Furthermore, certain antiretroviral drugs used to treat HIV
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may have neuropsychiatric side effects [7]. In addition to these
biological mechanisms that link HIV and mental illness, several
social and structural factors contribute to the poor mental health
of ALHIV. Many ALHIV have lost their biological parents and are
raised in extended families, or orphanages [8,9]. Caregivers of
orphans might be overburdened by the responsibility to care for,
and economically support an additional child or children [9].
Orphans often lack social and material support, feel unsafe at
home, are uncertain about their future and suffer from bereave-
ment following the loss of their biological parents [10-15]. ALHIV
frequently experience verbal abuse, bullying, violence, stigma
and discrimination [14,16-21], often internalize stigma and suffer
from self-blame [13,22,23]. Lastly, ALHIV have to cope with
issues related to the disclosure of their HIV status and the bur-
den of lifelong HIV treatment [12,24,25].
Mental health and substance use problems including depres-
sion, anxiety, alcohol abuse and illicit drug use can adversely affect
adherence to antiretroviral therapy (ART) [26-29]. Such problems
may lead to poor HIV treatment outcomes including unsup-
pressed viral load, loss to follow-up and premature mortality [30].
However, evidence on associations between mental health and
markers of HIV treatment response among ALHIV is inconclusive.
Some studies reported associations between mental health prob-
lems and low CD4 percentage, higher rates of unsuppressed HIV
viral load and HIV disease progression [10,31-34]. Still, other
studies found no evidence of such associations [10,35,36].
In low- and middle-income countries capacity to diagnose and
manage mental disorders is limited [37,38]. The South African
national treatment guidelines recommend routine mental health
screening as part of adherence support [39]. Still, the implemen-
tation of mental health services in the South African healthcare
system is inconsistent [40,41]. Routine mental health screening
is rarely done in public-sector ART programmes in South Africa,
and the vast majority of ART patients affected by mental health
problems remain undiagnosed and untreated [42].
We implemented routine mental health screening at a large
paediatric HIV clinic in Johannesburg, South Africa to improve
the identification and management of ALHIV affected by men-
tal health problems. In this report, we describe mental health
screening outcomes of ALHIV screened between February 1,
2018, and January 1, 2020, and examine associated patient
characteristics, and the increase in the odds of unsuppressed
viral load in ALHIV screening positive for a mental disorder.
2 | METHODS
2.1 | Study design
We followed a cohort of HIV-positive adolescents who
enrolled in HIV care at the Rahima Moosa Mother and Child
Hospital in Johannesburg, South Africa. The clinic participates
in the International epidemiology Databases to Evaluate AIDS
in Southern Africa (IeDEA-SA) and regularly transfers de->
identified routine clinical data of HIV-positive mothers, chil-
dren and adolescents to the IeDEA-SA data centres at the
University of Cape Town and the University of Bern [43].
2.2 | Setting and participants
Rahima Moosa Mother and Child Hospital is an academic, public
hospital. The clinic is the second largest ART clinic for the
treatment of children and ALHIV in Gauteng province. We
included ALHIV, aged 10 to 19 years, who received ART at
Rahima Moosa Mother and Child Hospital and participated at
least once in mental health screenings during the study period
from February 1, 2018, to January 1, 2020.
2.3 | Screening procedure
We offered adolescents aged 10 to 19 years old routine mental
health screening at every three monthly follow-up visit to the
clinic. The screening consisted of a pre-screen for depression,
anxiety, PTSD and substance use, followed by full screen among
adolescents with a positive pre-screen (Table 1). The full screen
included the Patient Health Questionnaire (PHQ-9), the Gener-
alized Anxiety Disorder 7 item (GAD-7) scale, the Primary Care
PTSD Screen for DSM-5 (PC-PTSD-5) and the CAGE Adapted to
Include Drugs (CAGE-AID) questionnaire (Table 1) [44-47]. Ado-
lescents who screened positive for depression in the pre-screen-
ing also received a full screening for suicidality using the three-
item screening tool from the Adolescent Innovations Project
(AIP) working with Adolescents living with HIV handbook [48]. In
addition to mental health questions, screenings included six basic
questions on food insecurity, assault, household conflicts and
socioeconomic situation. A clinical psychologist trained personnel
in administering the screening tools. The implementation of the
screening programme was jointly overseen by a senior doctor
and a social worker with experience in working with ALHIV with
mental health problems. Counsellors (68.2 %, 3044/4461) and
nurses (25.4%, 1131) conducted most screens. Few screens
(0.7%, 33) were conducted by doctors, social workers, or psy-
chologists and the information on the screener was missing for
5.7% (253) of the screens. Adolescents who screened positive in
a full screen were referred and assessed by a senior doctor and
social worker within the clinic and directed towards conclusive
management, which included referrals for counselling by onsite
psychologists, referral to psychiatric services, peer-support, fam-
ily meetings and adherence counselling.
2.4 | Measures
Adolescents who reported past or current thoughts of self-
harm or suicide or reported a previous suicide attempt
screened positive in the full screening for suicidality. A
PHQ-9 or GAD-7 score of 10 or higher was considered a
positive full screen for depression and anxiety, respectively.
For PTSD, a PC-PTSD-5 score of 3 or higher and for sub-
stance use a CAGE-AID score of 2 or higher were consid-
ered positive full screens. The final screening outcome was
classified as positive if an adolescent ever screened positive
in any full screen. It was classified as negative if an adoles-
cent always screened negative in pre-screens or positive in
pre-screens and negative in full screens. We defined the
CD4 count at the start of the study as the value closest to
the start of the study on February 1, 2018, within one year
prior, and one year after that date. The window for CD4 at
ART initiation was six months prior and one month after
ART initiation. We defined unsuppressed viral load as one
viral load above 400 copies/mL. We defined viral load at
screening as the measurement taken closest to the date of
screening, within hundred days before and one day after the
screening.
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2.5 | Statistical analysis
We used descriptive statistics to examine characteristics of
adolescents stratified by the final screening outcome. We cal-
culated percentages of adolescents who screened positive, at
the first screen, or ever, in pre- and full screens for depres-
sion, suicidality, anxiety, PTSD, substance use or any condition.
Full screens were done conditionally on a positive pre-screen.
For proportion, the denominator was the total population pre-
screened. We calculated the mean and standard deviation of
the PHQ-9, GAD-7, PC-PTSD-5 and CAGE-AID scores of ado-
lescents who had a positive full screen for the particular con-
dition. We estimated the percentage of adolescents who had a
positive full screen for two conditions for each possible pair of
conditions and plotted the results in a heat map.
We calculated unadjusted odds ratios (OR) and adjusted
odds ratios (aOR) with 95% confidence intervals (CI) for
patient characteristics associated with ever screening positive
in full screens for depression, suicidal concern, anxiety, PTSD
and alcohol/substance abuse using logistic regression. We con-
sidered a priori hypothesized predictors of mental health and
substance use problems including sociodemographic and clini-
cal characteristics, and factors describing the life circum-
stances of adolescents in univariable analysis. Variables
associated with a positive screen at a significance level of
a < 0.2 in univariable analysis were considered in multivari-
able analysis. Variables that were not significant at a < 0.05 in
multivariable analysis were eliminated from the final model
[60].
We calculated ORs and aORs with 95% CIs for associations
between positive full screens at the first screen and unsup-
pressed viral load at screening using logistic regression. Viral
load testing was routinely performed annually. Hence, viral load
testing was not necessarily performed on the day of mental
health screening. We restricted the analysis of associations
between positive full screens and unsuppressed viral load to
adolescents who had a viral load test performed within hun-
dred days before and one day after the screening. We did not
consider viral load tests performed later than one day after
screening because intervention following a positive mental
health screen might influence viral suppression, and therefore,
might distort associations between screening outcomes and
unsuppressed viral load. In multivariable analysis, we adjusted
for gender, age at screening (10 to 12, 13 to 15, or 16 to 19
years), regimen at screening (non-nucleoside reverse transcrip-
tase inhibitor [NNRTI]-based, protease inhibitor [PI]-based, or
other), age at ART initiation (<2, 2 to 4, 5 to 9, or 10 years or
older), CD4 cell count at ART initiation (<100, 100 to 199,
200 to 349, 350 to 499, ≥500 cells/µL or unknown) and regi-
men at ART initiation (NNRTI-based, PI-based, or other). These
potential confounders were selected a priori. In a sensitivity
analysis, we assessed associations of positive mental and sub-
stance use screens and unsuppressed viral load at a threshold
of above 1000 copies/mL. Statistical analysis was done in Stata
(Version 16, Stata Corporation, College Station, TX).
2.6 | Ethical considerations
The clinic has institutional ethical approval for the contribu-
tion of data to IeDEA. The Human Research Ethics Commit-
tee of the University of Cape Town, South Africa and the
Cantonal Ethics Committee, Bern, Switzerland granted per-
mission for analysis of this database. Institutional review
boards have granted waivers of informed consent as the
analyses use only de-identified data that are collected as
part of routine patient care.
3 | RESULTS
3.1 | Screening coverage
During the study period, 1203 ART patients aged 10 to 19
visited the clinic, of whom 1088 (90.4%) were screened (i.e. at
least pre-screened) and included in our study, of whom 381
(35.0%) underwent full screening for at least one condition.
The reasons for omitting screening in 115 adolescents (9.6%)
were not documented. On average, adolescents participating
in screenings were screened eight times (IQR 6 to 9) over a
median duration of 518 days (IQR 420 to 576) between first
and last screening.
3.2 | Characteristics of adolescents screened for
mental health and substance use problems
Tables 2 and 3 show demographic, clinical and other charac-
teristics adolescents screened. Half of the 1088 adolescents
screened were male. At the beginning of the study period, the
median age of the study population was 13 years (IQR 10 to
15), adolescents were receiving ART for a median duration of
9 years (IQR 6 to 11 years). At ART initiation, the median age
of adolescents was 3 years (IQR 1 to 7), median CD4 cell
count was 496 cells/µL (IQR 262 to 853; Table 2). Few ado-
lescents (5.9%) reported that they had experienced food inse-
curity, 15.3% reported that they had experienced physical
violence and 14.1% reported a current or past conflict at
home (Table 3).
3.3 | Screening outcomes and management of
adolescents with positive screening outcomes
Table 4 shows the proportions of adolescents who screened
positive in pre- and full screens for depression, suicidality, anx-
iety, PTSD, substance use or any of these conditions. Out of
all adolescents who were pre-screened, 6.9% had a positive
full screen for any condition at the first screen: 3.6% for
depression, 2.2% for suicidal concern, 1.9% for anxiety, 2.2%
for PTSD and 0.9% for alcohol/substance abuse. The preva-
lence of positive full screens increased with age. In repeated
screening, few additional adolescents screened positive in full
screens. In total, 8.9% of pre-screened adolescents ever
screened positive in a full screen for any condition: 4.4% for
depression, 2.7% for suicidal concern, 2.2% for anxiety, 3.5%
for PTSD and 1.7% for alcohol/substance abuse. Out of the
97 adolescents who screened positive in full screens, 97
(100.0%) were seen and assessed by a senior doctor and a
social worker, 16 (16.5%) were referred to and seen at the
psychiatry department, 27 (27.8%) seen by a clinical psycholo-
gist, 40 (41.2%) participated in peer support clubs and 18
(18.6%) participated in family meetings.
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Table 2. Demographic and clinical characteristics of adolescents screened for mental health and substance use problems in a paedi-
atric HIV clinic in South Africa
Final screening outcomea, n (%)
Negative Positive Total, n (%)
N = 991 N = 97 N = 1088
Characteristics at the start of the studyb
Gender
Male 498 (50.3) 51 (52.6) 549 (50.5)
Female 493 (49.7) 46 (47.4) 539 (49.5)
Years on ART
0 to 5 193 (19.5) 12 (12.4) 205 (18.8)
6 to 10 527 (53.2) 45 (46.4) 572 (52.6)
>10 271 (27.3) 40 (41.2) 311 (28.6)
Median (IQR) 9 (6 to 11) 10 (7 to 12) 9 (6 to 11)
Regimen
NNRTI-based 640 (64.6) 59 (60.8) 699 (64.2)
PI-based 336 (33.9) 38 (39.2) 374 (34.4)
Other 15 (1.5) 0 (0.0) 15 (1.4)
Age in years
9 to 12 522 (52.7) 16 (16.5) 538 (49.4)
13 to 15 304 (30.7) 25 (25.8) 329 (30.2)
16 to 19 165 (16.6) 56 (57.7) 221 (20.3)
Median (IQR) 12 (10 to 14) 16 (14 to 17) 13 (10 to 15)
CD4 count in cells/µL
<350 72 (7.3) 13 (13.4) 85 (7.8)
350 to 499 104 (10.5) 18 (18.6) 122 (11.2)
500 to 749 275 (27.7) 27 (27.8) 302 (27.8)
750+ 469 (47.3) 33 (34.0) 502 (46.1)
Unknown 71 (7.2) 6 (6.2) 77 (7.1)
Median (IQR) 766 (545 to 990) 671 (397 to 840) 747 (537 to 982
Characteristics at ART initiation
Regimen
NNRTI-based 562 (56.7) 73 (75.3) 635 (58.4)
PI-based 379 (38.2) 23 (23.7) 402 (36.9)
Other 50 (5.0) 1 (1.0) 51 (4.7)
Age in years
<2 386 (39.0) 15 (15.5) 401 (36.9)
2 to 4 225 (22.7) 29 (29.9) 254 (23.3)
5 to 9 279 (28.2) 40 (41.2) 319 (29.3)
10 to 19 101 (10.2) 13 (13.4) 114 (10.5)
Median (IQR) 3 (1 to 6) 5 (3 to 8) 3 (1 to 7)
CD4 count in cells/µL
<100 72 (7.3) 9 (9.3) 81 (7.4)
100 to 199 38 (3.8) 7 (7.2) 45 (4.1)
200 to 349 92 (9.3) 11 (11.3) 103 (9.5)
350 to 499 92 (9.3) 9 (9.3) 101 (9.3)
500+ 302 (30.5) 24 (24.7) 326 (30.0)
Unknown 395 (39.9) 37 (38.1) 432 (39.7)
Median (IQR) 505 (271 to 873) 410 (186 to 648) 496 (262 to 853)
Data are n (%) unless otherwise specified. ART, antiretroviral therapy; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibi-
tors; IQR, interquartile range.
a
The final screening outcome was classified as positive if an adolescent ever screened positive in any full screen or else (i.e. always negative pre-
screen or positive pre- and negative full screen) as negative;
b
beginning of the study period was February 01, 2018.
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3.4 | Co-occurrence of multiple mental health and
substance use problems at the first screen
Positive full screens for multiple conditions at the first screen
were common: among the adolescents who had a positive full
screen for one condition, 32.0% (24/75) had another positive
full screen, and 18.7% (14/75) had positive full screens for
two or more additional conditions. Figure 1 shows the co-
occurrence of positive full screens on the first screen for each
possible pair of conditions. Positive full screens for depression
and suicidality often co-occurred: 41.0% (16/39) of adoles-
cents who screened positive for depression also screened pos-
itive for suicidality. Other common co-occurrences include
positive depression screens among adolescents with anxiety
(45.0%, 9/20) or PTSD (41.7%, 10/24).
3.5 | Patient characteristics associated with ever
screening positive in full screens
Table 5 shows aORs for patient characteristics associated
with ever screening positive in full screens for mental health
and substance use problems. Younger age was associated with
lower odds of screening positive for all five conditions. More
specifically, adolescents aged between 10 and 12 years old
had 11 times lower odds of screening positive for any
condition (aOR 0.09, 95% CI 0.04 to 0.19) than those aged
16 to 19 years (Table 5). There were no gender differences in
the odds of positive screening for depression, suicidality, anxi-
ety or PTSD. However, girls and young women had much
lower odds of screening positive for substance abuse than
boys and young men (aOR 0.19, 95% CI 0.05 to 0.66). Experi-
ence of physical violence was associated with positive full
screen for suicidality, anxiety, PTSD and any condition and
household conflicts were associated with positive full screen
for depression, and any condition (Table 5).
3.6 | Associations between positive full screens at
the first screen and unsuppressed viral load at
screening
Three-quarters of the adolescents screened for mental health,
and substance use problems (74.6%, 812/1,088) had a viral
load test performed at screening (i.e. on the day of mental
health screening or within 100 days before or 1 day after
screening). They were included in the analysis of associations
between positive mental health screens and unsuppressed
viral load. The median time between viral load test and mental
health screening among adolescents included in this analysis
was 0 days (IQR 0 to 84 days). The prevalence of unsup-
pressed viral load was 17.4% (131/753) in adolescents who
Table 3. Life circumstances of adolescents screened for mental health and substance use problems at a paediatric HIV clinic in
South Africa
Final screening outcomea, n (%)
Negative Positive Total, n (%)
N = 991 N = 97 N = 1088
Experienced food insecurity
Never 936 (94.5) 87 (89.7) 1023 (94.0)
Currently or in the past 54 (5.4) 10 (10.3) 64 (5.9)
Unknown/refused/missing 1 (0.1) 0 (0.0) 1 (0.1)
Experienced physical violence
Never 844 (85.2) 75 (77.3) 919 (84.5)
Currently or in the past 146 (14.7) 21 (21.6) 167 (15.3)
Unknown/refused/missing 1 (0.1) 1 (1.0) 2 (0.2)
Conflict in household
Never 863 (87.1) 71 (73.2) 934 (85.8)
Currently or in the past 127 (12.8) 26 (26.8) 153 (14.1)
Unknown/refused/missing 1 (0.1) 0 (0.0) 1 (0.1)
Employment of household member
Never 35 (3.5) 2 (2.1) 37 (3.4)
Currently or in the past 955 (96.4) 95 (97.9) 1050 (96.5)
Unknown/refused/missing 1 (0.1) 0 (0.0) 1 (0.1)
Household grant
Never 190 (19.2) 24 (24.7) 214 (19.7)
Currently or in the past 745 (75.2) 72 (74.2) 817 (75.1)
Unknown/refused/missing 56 (5.7) 1 (1.0) 57 (5.2)
Questions regarding life circumstances were asked after each mental health and substance use screening. Data are numbers and percentages of
adolescents who reported the five life circumstances at any time during the study duration.
a
The final screening outcome was classified as positive if an adolescent ever screened positive in any full screen or else (i.e. always negative pre-
screen or positive pre- and negative full screen) as negative.
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screened negative for all conditions, and 33.9% (20/59) in
adolescents who screened positive for at least one condition.
Figure 2 shows ORs and aOR for associations between posi-
tive full screens for mental health or substance use problems
at the first screen and unsuppressed viral load at screening. In
unadjusted analysis, adolescents who screened positive in full
screens for depression (OR 2.56, 95% CI 1.16 to 5.67), suici-
dality (OR 3.02, 95% CI 1.06 to 8.62), PTSD (OR 3.51, 95%
CI 1.29 to 9.59), substance use (OR 9.03, 95% CI 2.23 to
36.53), or any condition (OR 2.43, 95% CI 1.38 to 4.31) had
higher odds of unsuppressed viral load than those who
screened negative for all five conditions. In the analysis
adjusted for gender, age at screening, regimen at screening
and CD4 cell count, regimen and age at ART initiation, posi-
tive full screen for depression (aOR 2.39, 95% CI 1.02 to
5.62), PTSD (aOR 3.18, 95% CI 1.11 to 9.07), substance use
(aOR 7.13, 95% CI 1.60 to 31.86) or any condition (aOR 2.17,
95% CI 1.17 to 4.02) remained associated with higher odds of
unsuppressed viral load (Figure 2). Results were similar in the
sensitivity analysis in which we used a threshold of 1000
copies per millilitre to define unsuppressed viral load (Fig-
ure S1). Positive screening for any condition remained associ-
ated with higher odds of unsuppressed viral load at the
threshold of above 1000 copies per millilitre in unadjusted
(OR 2.77, 95% CI 1.53 to 5.01) and adjusted sensitivity analy-
sis (aOR 2.36, 95% CI 1.25 to 4.47) (Figure S1).
4 | DISCUSSION
Overall, about 9% of adolescents screened positive for mental
health or substance use problems with a much higher preva-
lence among adolescents aged 16 to 19 years (19%) than
among those aged 10 to 12 years (2%). Depression was the
most common mental health problem, with over 4% of adoles-
cents screening positive for this condition. Only a few adoles-
cents (<2%) screened positive for substance abuse. Many
adolescents screened positive for more than one condition.
Table 4. Mental health and substance use screening outcomes of adolescents screened at a paediatric HIV clinic in South Africa
At the first screen, n (%) Ever, n (%)
Age in years Agee in years
10 to 12 13 to 15 16 to 19 Total 10 to 12 13 to 15 16 to 19 Total
Depressiona 501 (100.0) 339 (100.0) 247 (100.0) 1087 (100.0) 348 (100.0) 376 (100.0) 364 (100.0) 1088 (100.0)
Positive pre-screenb 41 (8.2) 68 (20.1) 59 (23.9) 168 (15.5) 19 (5.5) 70 (18.6) 103 (28.3) 192 (17.6)
Positive full screenb 5 (1.0) 10 (3.0) 24 (9.8) 39 (3.6) 2 (0.6) 8 (2.1) 38 (10.4) 48 (4.4)
PHQ-9c, mean (SD) 14.2 (5.0) 12.8 (3.4) 14.8 (4.1) 14.2 (4.0) 17.1 (8.6) 14.9 (4.0) 14.9 (4.2) 15.0 (4.2)
Suicidalitya 498 (100.0) 328 (100.0) 241 (100.0) 1067 (100.0) 348 (100.0) 375 (100.0) 364 (100.0) 1087 (100.0)
Positive full screenb 2 (0.4) 8 (2.4) 14 (5.8) 24 (2.2) 2 (0.6) 8 (2.1) 19 (5.2) 29 (2.7)
Anxietya 500 (100.0) 339 (100.0) 244 (100.0) 1083 (100.0) 348 (100.0) 376 (100.0) 364 (100.0) 1088 (100.0)
Positive pre-screenb 33 (6.6) 67 (19.8) 64 (26.2) 164 (15.1) 16 (4.6) 66 (17.6) 105 (28.8) 187 (17.2)
Positive full screenb 1 (0.2) 6 (1.8) 13 (5.5) 20 (1.9) 1 (0.3) 4 (1.1) 19 (5.2) 24 (2.2)
GAD-7c, mean (SD) 18.0 12.3 (1.7) 13.4 (2.5) 13.3 (2.5) 18.0 12.9 (2.6) 13.5 (3.0) 13.6 (3.0)
PTSDa 499 (100.0) 337 (100.0) 244 (100.0) 1080 (100.0) 347 (100.0) 376 (100.0) 364 (100.0) 1087 (100.0)
Positive pre-screenb 23 (4.6) 41 (12.2) 46 (18.9) 110 (10.2) 19 (5.5) 49 (13.0) 79 (21.7) 147 (13.5)
Positive full screenb 5 (1.0) 7 (2.1) 12 (5.0) 24 (2.2) 5 (1.4) 9 (2.4) 24 (6.6) 38 (3.5)
PC-PTSD-5c, mean (SD) 3.6 (0.9) 3.3 (0.5) 3.6 (0.7) 3.5 (0.7) 3.6 (0.5) 3.8 (0.8) 3.5 (0.7) 3.6 (0.7)
Substance usea 487 (100.0) 336 (100.0) 246 (100.0) 1069 (100.0) 346 (100.0) 376 (100.0) 364 (100.0) 1086 (100.0)
Positive pre-screenb 3 (0.6) 9 (2.7) 30 (12.2) 42 (3.9) 1 (0.3) 10 (2.7) 75 (20.6) 86 (7.9)
Positive full screenb 0 (0.0) 1 (0.3) 9 (3.7) 10 (0.9) 0 (0.0) 2 (0.5) 16 (4.4) 18 (1.7)
CAGE-AIDc, mean (SD) NA 2.0 2.2 (0.4) 2.2 (0.4) NA 3.0 (1.4) 2.3 (0.4) 2.3 (0.6)
Any conditiona,d 501 (100.0) 340 (100.0) 247 (100.0) 1088 (100.0) 348 (100.0) 376 (100.0) 364 (100.0) 1088 (100.0)
Positive pre-screenb 73 (14.6) 127 (37.4) 121 (49.0) 321 (29.5) 43 (12.4) 126 (33.5) 212 (58.2) 381 (35.0)
Positive full screenb 10 (2.0) 22 (6.5) 43 (17.4) 75 (6.9) 7 (2.0) 21 (5.6) 69 (19.0) 97 (8.9)
Data are n (%) unless otherwise specified. For proportion, the denominator was the total population pre-screened. Full screens were done condi-
tionally on a positive pre-screen. Full screen for suicidality was done conditionally on a positive pre-screen for depression. CAGE-AID, CAGE
Adapted to Include Drugs; GAD-7, Generalized Anxiety Disorder 7-item scale; NA, non-applicable; PC-PTSD-5, Primary Care Post-Traumatic Stress
Disorder Screen for DSM-5; PHQ, Patient Health Questionnaire; PTSD, post-traumatic stress disorder; SD, standard deviation.
a
Total population pre-screened.
b
numbers and percentages of patients who screened positive at the first screening or ever in any repeated screening during the study duration.
c
mean (SD) test scores of adolescents who screened positive in full screens.
d
any condition refers to depression, suicidality, anxiety or substance use.
e
age was assessed at the last screen.
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Older age, the experience of physical violence, and household
conflicts were associated with positive mental health screens.
One-third of adolescents who screened positive for a mental
health or substance use problem had an unsuppressed viral
load. A positive screen for mental health or substance use
problems was strongly associated with unsuppressed viral
load.
Our study has several strengths. It was conducted in a large
public ART clinic in South Africa. The majority of HIV-positive
adolescents live in sub-Saharan Africa and receive care in simi-
lar healthcare settings. Participants enrolled in our study
received only routine services that are the standard of care
for adolescent ART patients in South Africa. The study setting
and our “naturalistic” approach contribute to the external
validity of our study and make our results applicable to a large
proportion of adolescents globally. Our sample size was large
enough to conduct a multivariable analysis of factors associ-
ated with mental health and substance use problems. The
41% 23% 26% 5%
67% 33% 37% 12%
45% 40% 20% 10%
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20% 30% 20% 20%
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Figure 1. Co-occurrence of positive full screen for mental health and substance use conditions at the first screen. Percentage of adolescents
who had a positive full screen for the condition shown on the x-axis among those who had a positive full screen for the condition shown on the y-
axis. N represents the denominator. Darker colours represent higher values. PTSD, post-traumatic stress disorder.
Table 5. Patient characteristics associated with ever screening positive in full screens for mental health and substance use problems
among adolescents screened at a paediatric HIV in South Africa
Depression
aOR (95 CI)
Suicidality
aOR (95 CI)
Anxiety
aOR (95 CI)
PTSD
aOR (95 CI)
Substance use
aOR (95 CI)
Any condition
aOR (95 CI)
Gender
Male 1.00
Female 0.19 (0.05 to 0.66)
Age at screening
10 to 12 0.05 (0.01 to 0.21) 0.10 (0.02 to 0.41) 0.05 (0.01 to 0.37) 0.21 (0.08 to 0.56) 0.09 (0.04 to 0.19)
13 to 15 0.18 (0.08 to 0.40) 0.37 (0.16 to 0.87) 0.19 (0.06 to 0.56) 0.34 (0.16 to 0.75) 0.11 (0.02 to 0.48) 0.25 (0.15 to 0.42)
16 to 19 1.00 1.00 1.00 1.00 1.00 1.00
Experienced physical violence
Never 1.00 1.00 1.00
Currently or in
the past
3.44 (1.55 to 7.65) 2.74 (1.09 to 6.85) 4.31 (2.17 to 8.54)
Conflict in household
Never 1.00 1.00
Currently or in
the past
3.76 (1.97 to 7.17) 2.56 (1.53 to 4.28)
Data are adjusted odds ratios (aOR) and 95% confidence intervals (CI) for factors associated with ever screening positive in full screens for
depression, suicide, anxiety, PTSD, substance abuse and any condition. PTSD, Post-traumatic stress disorder.
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longitudinal study design allowed for repeated mental health
screening, and we could assess the period prevalence of posi-
tive mental health screens over two years.
Our results have to be interpreted in light of several limita-
tions. We used screening tools, which showed acceptable diag-
nostic accuracy for identifying individuals with Diagnostic and
Statistical Manual (DSM)-defined mental disorders in Western
and South African populations [44-47,49-52,61], but we could
not validate screening tools for our young HIV-positive study
population. The prevalence of positive screening tests in our
study was relatively low, and we possibly missed adolescents
with mental health or substance use problems during the pre-
or full screening. Screening tools were administered by clinic
staff and ALHIV may have underreported substance use or
symptoms of mental disorders as a result of social desirability
bias [62]. Despite these limitations, strong associations
between positive mental health screening tests and unsup-
pressed viral load demonstrate the clinical significance of posi-
tive screening tests for HIV treatment. We used data from
routinely performed viral load tests to examine associations
between mental health and unsuppressed viral load. One-
quarter of adolescents could not be included in this analysis
because they had no recent viral load test result available. For
one-quarter of adolescents, we used a viral load result from a
test that was performed about 3 months before the mental
health screening. Changes in viral load occurring between viral
load testing and mental health screening could distort associa-
tions between positive screens and unsuppressed viral load.
The prevalence of ALHIV with positive mental health
screening outcomes that we observed in this study was lower
than expected. About 10% to 20% of children and adolescents
worldwide are estimated to be affected by mental disorders
[63,64]. In ALHIV, the prevalence of mental disorders is sub-
stantially higher than in their HIV-negative peers [10,33,65].
For example in Malawi [66] and Nigeria [65], about 20% of
ALHIV were diagnosed with depression based on structured
diagnostic interviews [65], but in our study, only 4% screened
positive for depression with a higher prevalence in those aged
16 to 19 years (10%). Our estimates for the prevalence of
ALHIV with positive mental health screening outcomes are
also low when compared with other African studies using
mental health screening tools. In Johannesburg, one-third of
ALHIV (aged 16 years on average) screened positive for
depression and one-fifth reported substance use problems
[67]. Another study from Johannesburg found that 27% of
ALHIV (aged 16 years on average) screened positive for
depression, anxiety or post-traumatic stress disorder [14]. The
prevalence of positive depression screens in ALHIV was 25%
in Zambia [68], 26% in Rwanda [69], 32% in Malawi [66] and
reached up to 51% in Uganda [70,71]. Differences in the age
of study populations, screening or diagnostic tools and cut-offs
mean that these estimates are not directly comparably. Never-
theless, the low prevalence of ALHIV with positive mental
health screening outcomes in our study population suggests a
low sensitivity of our screening model, particularly in younger
adolescents.
Our study provides strong evidence for associations
between positive mental health screening outcome and viral
suppression. Existing evidence on these association is incon-
clusive. In a longitudinal study of children and adolescents liv-
ing with HIV from the US and Puerto Rico, those with
symptoms of anxiety had a 40% lower odds of having unsup-
pressed viral load (viral load >400 copies/mL). Symptoms of
attention deficit hyperactivity disorder, disruptive behaviour or
depression were not associated with viral load suppression
[31]. In Botswana, a cohort study found higher rates of unsup-
pressed viral load (viral load >400 copies/mL) in children and
adolescents who scored high for cognitive, emotional and
behavioural problems than in those with a lower score [32]. In
Windhoek, Namibia, a study found no evidence for associa-
tions between mental health screening tests and viral suppres-
sion [35]. In a study from New York City, disruptive behaviour
Depression 
Suicidality 
Anxiety 
PTSD 
Substance use 
Any MSD 
0.25 0.50 1.00 2.00 5.00 10.00
Odds Ratios
Unadjusted
Adjusted
Figure 2. Associations between positive full screens for mental health and substance use problems at the first screen and unsuppressed
viral load at screening. Adjusted and unadjusted odds ratios and 95% confidence intervals for associations between positive full screens for
depression, suicidality, anxiety, PTSD, substance use and any MSD at the first screen and unsuppressed viral load (i.e. viral load above 400 copies/
mL) at screening defined as the measurement taken closest to the date of screening, within 100 days before or 1 day after the screening. Odds
ratios were adjusted for gender, age at screening, regimen at screening, and age, CD4 cell count and regimen at ART initiation. Odds ratios were
plotted on a log scale. PTSD, post-traumatic stress disorder; MSD, mental health, or substance use disorders.
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disorder was strongly associated with unsuppressed viral load
at a threshold of greater than >1000 copies per millilitre [34].
In contrast, another studies from New York found no evidence
for associations between mental disorders and unsuppressed
viral load [36].
This study is a first step towards integrating evidence-based
mental healthcare into routine HIV services at a paediatric
public sector clinic in South Africa. Our research shows that
adolescents affected by mental health problems have
increased rates of unsuppressed viral load and need specific
clinical attention. Poor ART adherence in adolescents affected
by mental health problems is a plausible explanation for the
observed excess in odds of unsuppressed viral load in adoles-
cents with positive screening outcomes [26,27]. However, the
reverse direction of causality (i.e. psychiatric disorders sec-
ondary to HIV in people with insufficiently controlled HIV
infection) is also a possible mechanism [6,72]. Our study
demonstrates that the integration of routine screening and
management of mental health and substance use problems in
a high-burden public sector clinic in South Africa is feasible.
The approach requires monitoring, ongoing staff training and
improvement to ensure that its sensitivity is optimized over
time. Our screening model facilitates entry into onsite coun-
selling and psychosocial support services for further assess-
ment and if needed a referral to specialized psychiatric care.
Our experience shows that the response to mental health
conditions requires a tailored approach, adapted to patients’
healthcare needs and locally available health services. Adoles-
cents with more severe mental health problems require refer-
ral to specialized mental healthcare for proper diagnosis and
mental health treatment. Adolescents with less severe mental
health problems could often be managed within the ART clinic,
and common underlying psychological stressors including bul-
lying, conflicts in the home or food insecurity could be
addressed through onsite counselling and psychosocial sup-
port services.
Further studies are needed to validate screening tools for
ALHIV in low- and middle-income countries [53-55] and to
develop evidence-based interventions for improving mental
health and adherence in ALHIV affected by mental health
problems.
5 | CONCLUSIONS
ALHIV affected by mental health problems have increased
rates of unsuppressed viral load and need specific clinical
attention. The integration of routine mental health screening
in paediatric ART programmes is a feasible approach for iden-
tifying and referring adolescents with mental health and
adherence problems to counselling and psychosocial support
services and if needed to psychiatric care.
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Figure S1. Sensitivity analysis of associations between positive
full screens for mental health or substance use problems at
the first screen and viral load >1000 copies/mL at screening.
Adjusted and unadjusted odds ratios and 95% confidence
intervals for associations between positive full screens for
depression, suicidality, anxiety, PTSD, substance use and any
MSD at the first screen and viral load above 1000 copies/mL
at screening defined as the measurement taken closest to the
date of screening, within 100 days before or 1 day after the
screening. Odds ratios were adjusted for gender, age at
screening, regimen at screening, and age, CD4 cell count and
regimen at ART initiation. Odds ratios were plotted on a log
scale. PTSD, post-traumatic stress disorder; MSD, mental
health or substance use disorders.
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